The second most common neurodegenerative disorder after Alzheimer’s disease, Parkinson’s disease (PD) affects approximately one million Americans. Scientists are working toward discoveries to prevent or slow the disease early on, before it affects movement. Breakthrough studies include genetic research that could lead to targeted PD therapy.
Parkinson's Today Blog
PD Health @ Home features new weekly Parkinson’s disease (PD) wellness and education virtual events designed for the PD community. From now until June 12, we have new, exciting events scheduled that help promote mindfulness, highlight COVID-19 issues, exercise classes and more.
The prevalence of Parkinson’s disease (PD) is expected to double in the next 20 years. To date, there are no proven strategies for slowing the progression of PD. A calcium channel blocker medication used to treat hypertension called, Isradipine, has been shown to be neuroprotective in animal models of PD. Several studies of people also indicated the possibility that taking Isradipine may reduce the risk for PD.
As we rapidly approach the 2020 Care Partner Summit | Cumbre Para Cuidadores, now taking place on May 16 virtually, we are getting excited to learn with you!
James Beck, PhD, Parkinson's Foundation Chief Scientific Officer, gives us a high-level overview of what goes on in the brain that leads to a Parkinson’s disease (PD) diagnosis. In this Neuro Talk, Dr.
The coronavirus pandemic quickly changed our day to day lives and has given rise to an increase in healthcare appointments being administered through telemedicine (the distribution of health-related services and information using technology).
“Parkinson’s disease (PD) is not only happening in the brain,” said Malú Tansey, PhD, Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida (UF), a Parkinson’s Foundation Center of Excellence. “It’s a multisystem disease with many non-motor symptoms that manifest in the gastrointestinal system.”
As coronavirus continues to impact our daily life, we are committed to providing you with the latest updates and ways you can stay engaged with the Parkinson’s community. While you practice social and physical distancing, exercise your brain with our podcast playlist.
As the coronavirus pandemic evolves, we stay committed to providing you with the latest updates and ways you can stay engaged with the Parkinson’s community. Even though COVID-19 plays a role in our daily lives this month, April is still Parkinson’s Awareness Month and the Parkinson’s Foundation remains dedicated to bringing light to the prevalence of Parkinson’s.
Since the coronavirus (COVID-19) pandemic is currently part of our daily lives, the Parkinson’s Foundation is addressing the top questions about the virus and Parkinson’s disease (PD). On March 18, 2020 Michael S. Okun, MD, Parkinson’s Foundation Medical Director, and Fred Southwick, MD, Infectious Disease Expert and Author, both from the University of Florida Health, a Parkinson’s Foundation Center of Excellence, answered the top COVID-19 questions from our community.